Document is current
Any future updates will be listed below
-
Authors
Daher, André https://orcid.org/0000-0002-9747-0222
Aljayyoussi, Ghait
Pereira, Dhelio
Lacerda, Marcus V. G.
Alexandre, Márcia A. A.
Nascimento, Cristiana T.
Alves, Júlio Castro
da Fonseca, Laís Bastos
da Silva, Diego Medeiros Dias
Pinto, Douglas Pereira
Rodrigues, Danielle Fonseca
Silvino, Ana Carolina Rios
de Sousa, Taís Nóbrega
de Brito, Cristiana Ferreira Alves
ter Kuile, Feiko O.
Lalloo, David G.
-
Funding
Funding for this research was provided by:
Brazilian National Council of Research (CNPq) by the Fiocruz Programme of Excellence in Clinical Research (402131/2011-80)
- License Information
-
More Information
Article History
Received: 1 May 2019
Accepted: 7 September 2019
First Online: 23 September 2019
Ethics approval and consent to participate
: The Ethics Committee at the Tropical Medicine Research Centre of Rondonia (CEPEM Nº 31/11 CEP/CEPEM e 0018.0.046.000-11 CAAE–SISNEP and Plataforma Brasil Nº 74869 CEP/CEPEM e Nº 05462612.7.0000.0011 CAAE) reviewed and approved the clinical study protocol and informed consent from all participants was acquired before the study initiation, as declared in the ethics and regulatory statement. All signed informed consent forms are kept for at least 5 years after the study end.
: This manuscript does not contain any individualized data. The confidentiality of the patients’ records has been observed according to ethical regulations.
: The authors declare following competing interests and financial disclosure: André Daher is an employee of the Institute of Drug Technology (Farmanguinhos), Oswaldo Cruz Foundation (Fiocruz), a Brazilian governmental institution of Ministry of Health. Farmanguinhos is one of the study sponsors. He was involved in the study design, decision to publish, and preparation of the manuscript. Farmanguinhos does not sell medicine on the market. The Brazilian Ministry of Health exclusively drives its drug production. These disclosures do not alter our adherence policies on sharing data and materials. There are no restrictions on the sharing of data and/or materials.
